Author Question: What should the nurse explain to a client with Addison disease as the reason for needing ... (Read 20 times)

EY67

  • Hero Member
  • *****
  • Posts: 531
What should the nurse explain to a client with Addison disease as the reason for needing mineralocorticoid replacement therapy?
 
  1. Mineralocorticoids will reduce excessive serum glucose levels.
  2. Mineralocorticoids will mimic the action of cortisol.
  3. Mineralocorticoids will mimic the action of aldosterone.
  4. Mineralocorticoids will reduce harmful bronzing of the skin.

Question 2

The nurse would question the administration of mineralocorticoid replacement therapy for which client?
 
  1. Client with a defect in the stimulation of aldosterone secretion
  2. Client with a defect in aldosterone sensitivity
  3. Client with a defect in the secretion of aldosterone
  4. Client with Conn syndrome



pratush dev

  • Sr. Member
  • ****
  • Posts: 321
Answer to Question 1

Correct Answer: 3
Rationale 1: This is not an indication for use of mineralocorticoids.
Rationale 2: Mineralocorticoids do not mimic the action of cortisol.
Rationale 3: Mineralocorticoids, in addition to glucocorticoids, are indicated for use in clients with adrenocortical insufficiency.
Rationale 4: Bronzing of the skin would not be affected by the use of mineralocorticoids, and is not harmful to clients with Addison disease.
Global Rationale: Mineralocorticoids, in addition to glucocorticoids, are indicated for use in clients with adrenocortical insufficiency. They do not mimic the action of cortisol or affect the bronzing of the skin. Serum glucose levels are not affected.

Answer to Question 2

Correct Answer: 4
Rationale 1: This client should receive mineralocorticoid replacement.
Rationale 2: This client should receive mineralocorticoid replacement.
Rationale 3: This client should receive mineralocorticoid replacement.
Rationale 4: A client with Conn syndrome already has oversecretion of aldosterone and does not require mineralocorticoid replacement therapy.
Global Rationale: A client with Conn syndrome already has oversecretion of aldosterone and does not require mineralocorticoid replacement therapy. Mineralocorticoid replacement is used to treat the other conditions.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Astigmatism is the most common vision problem. It may accompany nearsightedness or farsightedness. It is usually caused by an irregularly shaped cornea, but sometimes it is the result of an irregularly shaped lens. Either type can be corrected by eyeglasses, contact lenses, or refractive surgery.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Hypertension is a silent killer because it is deadly and has no significant early symptoms. The danger from hypertension is the extra load on the heart, which can lead to hypertensive heart disease and kidney damage. This occurs without any major symptoms until the high blood pressure becomes extreme. Regular blood pressure checks are an important method of catching hypertension before it can kill you.

Did you know?

Chronic marijuana use can damage the white blood cells and reduce the immune system's ability to respond to disease by as much as 40%. Without a strong immune system, the body is vulnerable to all kinds of degenerative and infectious diseases.

Did you know?

The shortest mature adult human of whom there is independent evidence was Gul Mohammed in India. In 1990, he was measured in New Delhi and stood 22.5 inches tall.

For a complete list of videos, visit our video library